TDO2 is overexpressed in human glioma cells, and this phenomenon correlates with the production of kynurenine and with the expression of AhR target genes, thus indicating the production of a sufficiently large amount of kynurenine for AhR activation [71]. This evidence concerns the gene TDO2 and central nervous system cancer.